Doctor profile · Federal record
Dr. Thomasina Anderson-Sharpe, MD
Family Medicine Physician (CMS: Family Practice) · Mobile, AL
- NPI 1023085669
- Accepts Medicare
- 34 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
100 N Florida St Ste C-1
Mobile, AL 366073010
(251) 288-5655
fax (251) 298-8904 - Mailing address
-
601 S Harbour Island Blvd Ste 200
Tampa, FL 336025925
Credentials & registration
- NPI registered
- March 2006 — 20 yrs on file
- Profile last updated
- January 22, 2026
- Year of graduation
- 1992 — 34 yrs since
- Specialty taxonomy
- 207Q00000X — NUCC code
- State license (1)
- Alabama #18229
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1023085669. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,230
Distinct HCPCS
10
Medicare allowed
$86,724
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,427 | 167 | $0 | |
96372 |
Injection of drug or substance under skin or into muscle | 297 | 194 | $12 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 259 | 207 | $109 | |
J0696 |
Injection, ceftriaxone sodium, per 250 mg | 179 | 45 | $0 | |
87804 |
Detection test by immunoassay with direct visual observation for influenza virus | 138 | 66 | $16 | |
J1885 |
Injection, ketorolac tromethamine, per 15 mg | 103 | 45 | $1 | |
87811 |
Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 92 | 88 | $39 | |
0241U |
Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | 90 | 87 | $138 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 82 | 75 | $157 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 76 | 76 | $145 |
In context: peer comparison
Among 19 peers in this city , average services per provider: 77. This provider delivers 42× the peer median.Open Payments
Industry payments received
All-time total
$274
Transactions
9
Manufacturers
3
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Gilead Sciences, Inc. | 6 | $211.97 | |
| ViiV Healthcare Company | 2 | $38.45 | |
| Merck Sharp & Dohme LLC | 1 | $23.56 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,056
Patients
833
Total drug cost
$19,417
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Amoxicillin-Clavulanate Potass (Amoxicillin/Potassium Clav) | Brand | 191 | 176 | $2,308 |
| Prednisone | Generic | 108 | 96 | $273 |
| Levothyroxine Sodium | Generic | 85 | 44 | $1,340 |
| Cefdinir | Generic | 81 | 79 | $1,961 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 75 | 64 | $1,634 |
| Azithromycin | Generic | 75 | 67 | $367 |
| Atorvastatin Calcium | Generic | 74 | 31 | $954 |
| Fluticasone Propionate | Generic | 61 | 43 | $733 |
| Lagevrio (Eua) (Molnupiravir) | Brand | 54 | 52 | $4,779 |
| Celecoxib | Generic | 50 | 27 | $2,841 |
Hospital affiliations
Frequently asked questions
What is Dr. Thomasina Anderson-Sharpe's medical specialty?
Dr. Thomasina Anderson-Sharpe practices Family Medicine Physician in Mobile, AL.
Where does Dr. Thomasina Anderson-Sharpe practice?
Dr. Thomasina Anderson-Sharpe practices at 100 N Florida St Ste C-1, Mobile, AL 366073010. Office phone: 2512885655.
What is Dr. Thomasina Anderson-Sharpe's NPI?
Dr. Thomasina Anderson-Sharpe's National Provider Identifier (NPI) is 1023085669, issued by NPPES.
Does Dr. Thomasina Anderson-Sharpe accept Medicare assignment?
Yes. Dr. Thomasina Anderson-Sharpe accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Thomasina Anderson-Sharpe commonly perform?
Top Medicare-reported procedures in 2023: Injection, dexamethasone sodium phosphate, 1 mg (HCPCS J1100); Injection of drug or substance under skin or into muscle (HCPCS 96372); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.